Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;47(7):945-952.
doi: 10.1007/s00270-024-03702-3. Epub 2024 Apr 23.

Adding Short to Left Gastric Artery Embolization for the Treatment of Obesity: Safety and Effectiveness

Affiliations

Adding Short to Left Gastric Artery Embolization for the Treatment of Obesity: Safety and Effectiveness

Raphaël di Giuseppe et al. Cardiovasc Intervent Radiol. 2024 Jul.

Abstract

Purpose: This study assessed the safety and effectiveness of a technical modification that involves adding short gastric artery (SGA) embolization to left gastric artery (LGA) embolization.

Material and methods: This retrospective single-center study analyzed twenty obese patients (median age of 53.5 (30-73)) who were not eligible for bariatric surgery and underwent bariatric embolization with 300-500-µm microspheres in addition to a lifestyle counseling program between March 2021 and July 2022. Eight patients had LGA + SGA embolization, and twelve had LGA embolization alone. The primary outcome measure was total body weight loss (TBWL) at 6 months in the SGA + LGA and the LGA-only cohorts. Safety was assessed, defined as the 30-day adverse events rate according to the SIR classification.

Results: The mean 6-month post-embolization TBWL in the SGA + LGA cohort was 7.3 kg (95%CI 2.1-12.4; p = .01) and 4.1 kg (95%CI 0.4-8.6; p = 0.034) in the LGA-only cohort (mean difference - 3.1 kg ± 2.8; 95%CI (- 9.1-2.8); p = .28). The mean 6-month post-embolization TBWL in the entire cohort was 5.3 kg (p < .01). The rate of complications was similar between the two groups.

Conclusion: Combined SGA and LGA embolization is safe and effective to treat obesity. Larger studies are needed to determine whether SGA + LGA embolization results in more significant weight loss than LGA embolization alone.

Keywords: Bariatric medicine; Embolization, Therapeutic; Obesity; Weight loss.

PubMed Disclaimer

References

    1. Reddy VY, Neužil P, Musikantow D, et al. Transcatheter bariatric embolotherapy for weight reduction in obesity. J Am Coll Cardiol. 2020;76(20):2305–17. - DOI - PubMed
    1. Weiss CR, Abiola GO, Fischman AM, et al. Bariatric embolization of arteries for the treatment of obesity (BEAT Obesity) trial: results at 1 year. Radiology. 2019;291(3):792–800. - DOI - PubMed
    1. Loukas M, Wartmann CT, Louis RG Jr, et al. The clinical anatomy of the posterior gastric artery revisited. Surg Radiol Anat. 2007;29(5):361–6. - DOI - PubMed
    1. Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–6. - DOI - PubMed
    1. Vanderbecq Q, Grégory J, Dana J, et al. Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia. Diagn Interv Imaging. 2022;104(3):123–32. - DOI - PubMed